Compare Global X CleanTech (CTEC) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Global X CleanTech trades at $55.45 (market cap $25.33M), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 67.5× Global X CleanTech's market cap, and Nuvation Bio Inc. Class A Common Stock is more actively traded (5,448,712 versus 2,662). Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| CTEC | NUVB | |
|---|---|---|
Market Cap | $25.33M | $1.71B |
Volume | 2,662 | 5,448,712 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $9.54 |
52-Week Low | $50.82 | $3.41 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | — | $1.30B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
